Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02734251 · ClinicalTrials.gov registry record · NA
Effect of Relora Supplement on Anxiety, Cognitive Performance & Mood Tested After Induced Stress
A NA study of Mood (Psychological Function), sponsored by InterHealth Nutraceuticals.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT02734251 is a NA study of Mood (Psychological Function) that has completed, run by InterHealth Nutraceuticals. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02734251, a NA study of Mood (Psychological Function), has completed, sponsored by InterHealth Nutraceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The present randomized, double-blind, placebo-controlled crossover trial aims to evaluate the effects of Relora supplementation on responses to induced stress produced by a combination of cognitive and physiologic stressors in healthy men and women. The effects of the supplement, compared with a placebo, will be evaluated using measures to assess anxiety \[State-Trait Anxiety Inventory-Part 1 (STAI-Part 1), mood \[Bond-Lader Visual Analog Scale (VAS)\], hypothalamic-pituitary-adrenal axis activation (salivary cortisol) and cognitive function (cognitive flexibility, reaction time, processing speed, attention, sustained attention, working memory, and executive function). Testing will be completed at the beginning and end of 7-d supplementation periods with the active and placebo products to assess both the acute effects and the "acute-on-chronic" effects following one week of daily use.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Relora
Study Locations (1)
Florida
- MB Clinical Research - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02734251
The ClinicalTrials.gov registry entry for NCT02734251 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InterHealth Nutraceuticals, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mood (Psychological Function) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02734251 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02734251 about?
NCT02734251 is a clinical study titled "Effect of Relora Supplement on Anxiety, Cognitive Performance & Mood Tested After Induced Stress". The present randomized, double-blind, placebo-controlled crossover trial aims to evaluate the effects of Relora supplementation on responses to induced stress produced by a combination of cognitive and physiologic stressors in healthy men and women. The effects of the supplement, compared with a pla...
What is the current status of trial NCT02734251?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2016-02.
What conditions does trial NCT02734251 study?
This clinical trial studies the following conditions: Mood (Psychological Function).
What interventions are being tested in trial NCT02734251?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Relora (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02734251?
This trial is sponsored by InterHealth Nutraceuticals, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02734251 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.